Beijing Science Sun Pharmaceutical Co., Ltd. Share Price
Equities
300485
CNE100002110
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.15 CNY | +1.75% | +8.23% | -23.04% |
Sales 2022 | 735M 102M 8.49B | Sales 2023 | 477M 66.03M 5.51B | Capitalization | 5.1B 707M 58.98B |
---|---|---|---|---|---|
Net income 2022 | 205M 28.4M 2.37B | Net income 2023 | 103M 14.27M 1.19B | EV / Sales 2022 | 6.33 x |
Net cash position 2022 | 1.12B 155M 12.97B | Net cash position 2023 | 1.17B 163M 13.57B | EV / Sales 2023 | 8.24 x |
P/E ratio 2022 |
27.9
x | P/E ratio 2023 |
50.4
x | Employees | - |
Yield 2022 |
0.72% | Yield 2023 |
0.21% | Free-Float | 41.18% |
1 day | +1.75% | ||
1 week | +8.23% | ||
Current month | +6.54% | ||
1 month | -4.34% | ||
3 months | +13.04% | ||
6 months | -28.51% | ||
Current year | -23.04% |
Managers | Title | Age | Since |
---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 60 | 05/01/05 |
Ning Zhang
ADM | Chief Administrative Officer | 45 | 28/21/28 |
Meng Wei Song
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/01/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yan Heng Song
BRD | Director/Board Member | 51 | 26/01 |
Xue Feng Wang
BRD | Director/Board Member | 46 | 01/99/01 |
Biao Ma
CEO | Chief Executive Officer | 60 | 05/01/05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
07/24/07 | 8.15 | +1.75% | 6 081 968 |
06/24/06 | 8.01 | +4.71% | 6,755,220 |
30/24/30 | 7.65 | +1.59% | 4,639,700 |
End-of-day quote Shenzhen S.E., May 07, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.04% | 535M | |
+33.44% | 690B | |
+26.43% | 546B | |
-5.09% | 358B | |
+19.06% | 323B | |
+4.84% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- 300485 Stock